γ-2-MSH (41-58), amide is derived from γ-2-MSH. γ-2-MSH is a twelve amino acid peptide that is derived from the N-terminal fragment of proopiomelanocortin (POMC) and contains the His-Phe-Arg-Trp motif common to all melanocortin endogenous agonist ligands.
γ-2-MSH (41-58), amide is a synthetic peptide fragment derived from the melanocyte-stimulating hormone (MSH) family, specifically corresponding to amino acids 41-58 of the proopiomelanocortin (POMC) precursor. Characterized by its amidated C-terminus, this peptide is notable for its structural similarity to endogenous γ-MSH peptides, which play significant roles in melanocortin receptor signaling. The sequence and modifications of γ-2-MSH (41-58), amide make it a valuable tool for probing peptide-receptor interactions, dissecting the functional domains of POMC-derived peptides, and exploring the physiological regulation of melanocortin pathways in diverse biochemical contexts.
Receptor Binding Studies: The peptide fragment is widely utilized in research focused on the specificity and affinity of melanocortin receptor subtypes, such as MC3R and MC4R. By employing γ-2-MSH (41-58), amide in ligand-binding assays, investigators can delineate the structural determinants responsible for receptor recognition and activation. Its defined sequence allows for precise mapping of ligand-receptor interactions, supporting studies aimed at understanding the molecular basis of signal transduction within the melanocortin system.
Peptide Structure-Function Analysis: Structural biologists and peptide chemists employ this synthetic fragment to elucidate the relationship between primary sequence, conformational dynamics, and biological activity. Through site-directed mutagenesis, alanine scanning, or comparative analysis with related MSH peptides, γ-2-MSH (41-58), amide serves as a reference compound for identifying critical residues involved in receptor activation and downstream signaling. Such studies facilitate the rational design of novel peptide analogs with tailored functional properties.
Pharmacological Profiling: The compound is instrumental in pharmacological assays designed to characterize agonist or antagonist activity at melanocortin receptors. Researchers utilize γ-2-MSH (41-58), amide to generate dose-response curves, assess selectivity across receptor subtypes, and benchmark the efficacy of newly synthesized peptide derivatives. These investigations provide foundational data for the development of selective modulators targeting melanocortin signaling pathways.
Cellular Signaling Investigations: In cellular models, the peptide can be applied to stimulate or modulate intracellular signaling cascades downstream of melanocortin receptors. Its use enables the dissection of second messenger pathways, such as cAMP accumulation or calcium flux, in response to receptor engagement. By comparing the cellular responses elicited by γ-2-MSH (41-58), amide with those induced by other MSH fragments, researchers gain insight into the nuanced regulation of melanocortin-mediated physiological processes.
Peptide Synthesis and Analytical Method Development: γ-2-MSH (41-58), amide also holds value as a standard or reference material in peptide synthesis optimization and analytical validation. Its well-characterized sequence and defined modifications make it suitable for calibrating chromatographic methods, mass spectrometry protocols, and purity assessment workflows. Laboratories engaged in the production, purification, or quantitative analysis of bioactive peptides benefit from employing this compound as a benchmark for method development and quality control.
1. TMEM16F and dynamins control expansive plasma membrane reservoirs
2. Urinary Metabolites Associated with Blood Pressure on a Low-or High-Sodium Die
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.